# A Study of E7389 in Advanced/Metastatic Breast Cancer Patients

> **NCT00097721** · PHASE2 · COMPLETED · sponsor: **Eisai Inc.** · enrollment: 104 (actual)

## Conditions studied

- Breast Neoplasms

## Interventions

- **DRUG:** E7389

## Key facts

- **NCT ID:** NCT00097721
- **Lead sponsor:** Eisai Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** 2006-11
- **Final completion:** 2006-11
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2013-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00097721

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00097721, "A Study of E7389 in Advanced/Metastatic Breast Cancer Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00097721. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*